Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium

British Journal of Haematology

Volumn 175, Issue 1, 2016, Pages 87-101

  Schinasi, Leah H ^a   Brown, Elizabeth E ^b   Camp, Nicola J ^c   Wang, Sophia S ^d   Hofmann, Jonathan N ^e   Chiu, Brian C ^f   Miligi, Lucia ^g   Beane Freeman, Laura E ^e   de Sanjose, Silvia ^h   Bernstein, Leslie ^d   Monnereau, Alain ⁱ   Clavel, Jacqueline ⁱ   Tricot, Guido J ^j   Atanackovic, Djordje ^c   Cocco, Pierluigi ^k   Orsi, Laurent ⁱ   Dosman, James A ^l   McLaughlin, John R ^m   Purdue, Mark P ^e   Cozen, Wendy ⁿ   Spinelli, John J ^o   de Roos, Anneclaire J ^a   more..

^a DREXEL UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g INSTITUTE FOR THE STUDY AND PREVENTION OF CANCER   (Italy)

^h CATALAN INSTITUTE OF ONCOLOGY   (Spain)

ⁱ PARIS DESCARTES UNIVERSITY   (France)

^j UNIVERSITY OF IOWA   (United States)

^k UNIVERSITY OF CAGLIARI   (Italy)

^l UNIVERSITY OF SASKATCHEWAN   (Canada)

^m Health Quality Ontario   (United States)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

epidemiology; family history; lympho haematopoietic malignancies; lymphoma; multiple myeloma

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNICITY; FAMILY HISTORY; FEMALE; FIRST-DEGREE RELATIVE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; INHERITANCE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84988515957     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14199     Document Type: Article

References (47)

1. Ahmed, B., Estey, E., Manning, J., David, C., Keating, M.J., Kantarjian, H. & Tsimberidou, A.M. (2006) Anaplastic large cell lymphoma with involvement of the pancreas presenting as panniculitis in a patient with a history of acute myeloid leukemia–case report and review of the literature. Haematologica, 91, ECR55.
2. Alexander, D.D., Mink, P.J., Adami, H.O., Cole, P., Mandel, J.S., Oken, M.M. & Trichopoulos, D. (2007) Multiple myeloma: a review of the epidemiologic literature. International Journal of Cancer, 120, 40–61.
3. Altieri, A., Chen, B., Bermejo, J.L., Castro, F. & Hemminki, K. (2006) Familial risks and temporal incidence trends of multiple myeloma. European Journal of Cancer, 42, 1661–1670.
4. Andreotti, G., Birmann, B., de Roos, A.J., Spinelli, J., Cozen, W., Camp, N.J., Moysich, K., Chiu, B., Steplowski, E., Krzystan, J., Boffetta, P., Benhaim-Luzon, V., Brennan, P., de Sanjosé, S., Costas, L., Costantini, A.S., Miligi, L., Cocco, P., Becker, N., Foretova, L., Maynadie, M., Nieters, A., Staines, A., Tricot, G., Milliken, K., Weisenburger, D., Zheng, T., Baris, D. & Purdue, M.P. (2013) A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium. Cancer Epidemiology Biomarkers and Prevention, 22, 1620–1627.
5. Baris, D., Silverman, D.T., Brown, L.M., Swanson, G.M., Hayes, R.B., Schwartz, A.G., Liff, J.M., Schoenberg, J.B., Pottern, L.M., Greenberg, R.S. & Stewart, P.A. (2004) Occupation, pesticide exposure and risk of multiple myeloma. Scandinavian Journal Work Environment and Health, 30, 215–222.
6. Bizzaro, N. & Pasini, P. (1990) Familial occurrence of multiple myeloma and monoclonal gammopathy of undetermined significance in 5 siblings. Haematologica, 75, 58–63.
7. Bourguet, C.C., Grufferman, S., Delzell, E., DeLong, E.R. & Cohen, H.J. (1985) Multiple myeloma and family history of cancer. A case-control study. Cancer, 56, 2133–2139.
8. Broderick, P., Chubb, D., Johnson, D.C., Weinhold, N., Forsti, A., Lloyd, A., Olver, B., Ma, Y.P., Dobbins, S.E., Walker, B.A., Davies, F.E., Gregory, W.A., Child, J.A., Ross, F.M., Jackson, G.H., Neben, K., Jauch, A., Hoffmann, P., Muhleisen, T.W., Nothen, M.M., Moebus, S., Tomlinson, I.P., Goldschmidt, H., Hemminki, K., Morgan, G.J. & Houlston, R.S. (2012) Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nature Genetics, 44, 58–61.
9. Brown, L.M., Linet, M.S., Greenberg, R.S., Silverman, D.T., Hayes, R.B., Swanson, G.M., Schwartz, A.G., Schoenberg, J.B., Pottern, L.M. & Fraumeni, Jr, J.F. (1999) Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer, 85, 2385–2390.
10. Camp, N.J., Werner, T.L. & Cannon-Albright, L.A. (2008) Familial myeloma. New England Journal of Medicine, 359, 1734–1735; author reply 1735.
11. Campa, D., Martino, A., Sainz, J., Buda, G., Jamroziak, K., Weinhold, N., Vieira Reis, R.M., Garcia-Sanz, R., Jurado, M., Rios, R., Szemraj-Rogucka, Z., Marques, H., Lesueur, F., Bugert, P., Moreno, V., Szemraj, J., Orciuolo, E., Gemignani, F., Rossi, A.M., Dumontet, C., Petrini, M., Goldschmidt, H., Landi, S. & Canzian, F. (2012) Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. British Journal of Haematology, 157, 331–338.
12. Casey, R., Brennan, P., Becker, N., Boffetta, P., Cocco, P., Domingo-Domenech, E., Foretova, L., Nieters, A., de Sanjosé S.S., Staines, A., Vornanen, M. & Maynadie, M. (2006) Influence of familial cancer history on lymphoid neoplasms risk validated in the large European case-control study epilymph. European Journal of Cancer, 42, 2570–2576.
13. Chang, E.T., Smedby, K.E., Hjalgrim, H., Glimelius, B. & Adami, H.O. (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. Journal of the National Cancer Institute, 98, 61–68.
14. Chubb, D., Weinhold, N., Broderick, P., Chen, B., Johnson, D.C., Forsti, A., Vijayakrishnan, J., Migliorini, G., Dobbins, S.E., Holroyd, A., Hose, D., Walker, B.A., Davies, F.E., Gregory, W.A., Jackson, G.H., Irving, J.A., Pratt, G., Fegan, C., Fenton, J.A., Neben, K., Hoffmann, P., Nothen, M.M., Muhleisen, T.W., Eisele, L., Ross, F.M., Straka, C., Einsele, H., Langer, C., Dorner, E., Allan, J.M., Jauch, A., Morgan, G.J., Hemminki, K., Houlston, R.S. & Goldschmidt, H. (2013) Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nature Genetics, 45, 1221–1225.
15. Coleman, E.A., Lynch, H., Enderlin, C., Stewart, B., Thome, S.D., Kennedy, R., Richardson-Nelson, T. & Barlogie, B. (2009) Initial report of a family registry of multiple myeloma. Cancer Nursing, 32, 456–464.
16. Cozen, W., Gebregziabher, M., Conti, D.V., Van Den Berg, D.J., Coetzee, G.A., Wang, S.S., Rothman, N., Bernstein, L., Hartge, P., Morhbacher, A., Coetzee, S.G., Salam, M.T., Wang, W., Zadnick, J. & Ingles, S.A. (2006) Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma. Cancer Epidemiology Biomarkers and Prevention, 15, 2285–2291.
17. Crowther-Swanepoel, D., Broderick, P., Di Bernardo, M.C., Dobbins, S.E., Torres, M., Mansouri, M., Ruiz-Ponte, C., Enjuanes, A., Rosenquist, R., Carracedo, A., Jurlander, J., Campo, E., Juliusson, G., Montserrat, E., Smedby, K.E., Dyer, M.J., Matutes, E., Dearden, C., Sunter, N.J., Hall, A.G., Mainou-Fowler, T., Jackson, G.H., Summerfield, G., Harris, R.J., Pettitt, A.R., Allsup, D.J., Bailey, J.R., Pratt, G., Pepper, C., Fegan, C., Parker, A., Oscier, D., Allan, J.M., Catovsky, D. & Houlston, R.S. (2010) Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nature Genetics, 42, 132–136.
18. Eriksson, M. & Hallberg, B. (1992) Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study. Cancer Causes and Control, 3, 63–67.
19. Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. & Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon, France.
20. Ghosh, S., McLaughlin, J.R., Spinelli, J.J., Dosman, J.A., McDuffie, H.H. & Pahwa, P. (2011) Multiple myeloma and occupational exposures: a population-based case-control study. Journal of Occupational and Environmental Medicine, 53, 641–646.
21. Grass, S., Preuss, K.D., Ahlgrimm, M., Fadle, N., Regitz, E., Pfoehler, C., Murawski, N. & Pfreundschuh, M. (2009) Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. Lancet Oncology, 10, 950–956.
22. Greenberg, A.J., Rajkumar, S.V. & Vachon, C.M. (2012) Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Blood, 119, 5359–5366.
23. Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D.R., Chen, H.S., Feuer, E.J. & Cronin, K.A. (2015) SEER Cancer Statistics Review, 1975-2011, based on November 2013 SEER data submission.
24. Jain, M., Ascensao, J. & Schechter, G.P. (2009) Familial myeloma and monoclonal gammopathy: a report of eight African American families. American Journal of Hematology, 84, 34–38.
25. Koura, D.T. & Langston, A.A. (2013) Inherited predisposition to multiple myeloma. Therapeutic Advances in Hematology, 4, 291–297.
26. Kristinsson, S.Y., Bjorkholm, M., Goldin, L.R., Blimark, C., Mellqvist, U.H., Wahlin, A., Turesson, I. & Landgren, O. (2009a) Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. International Journal of Cancer, 125, 2147–2150.
27. Kristinsson, S.Y., Goldin, L.R., Bjorkholm, M., Koshiol, J., Turesson, I. & Landgren, O. (2009b) Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica, 94, 1581–1589.
28. Landgren, O., Linet, M.S., McMaster, M.L., Gridley, G., Hemminki, K. & Goldin, L.R. (2006) Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. International Journal of Cancer, 118, 3095–3098.
29. Landgren, O., Kristinsson, S.Y., Goldin, L.R., Caporaso, N.E., Blimark, C., Mellqvist, U.H., Wahlin, A., Bjorkholm, M. & Turesson, I. (2009) Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood, 114, 791–795.
30. Lynch, H.T., Watson, P., Tarantolo, S., Wiernik, P.H., Quinn-Laquer, B., Isgur, B.K., Huiart, L., Olopade, O.I., Sobol, H., Sanger, W., Hogg, D. & Weisenburger, D. (2005) Phenotypic heterogeneity in multiple myeloma families. Journal of Clinical Oncology, 23, 685–693.
31. McDuffie, H.H., Pahwa, P., Karunanayake, C.P., Spinelli, J.J. & Dosman, J.A. (2009) Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects. BMC Cancer, 9, 70.
32. Miligi, L., Seniori, C.A., Crosignani, P., Fontana, A., Masala, G., Nanni, O., Ramazzotti, V., Rodella, S., Stagnaro, E., Tumino, R., Vigano, C., Vindigni, C. & Vineis, P. (1999) Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. American Journal of Industrial Medicine, 36, 60–69.
33. Nuyujukian, D.S., Voutsinas, J., Bernstein, L. & Wang, S.S. (2014) Medication use and multiple myeloma risk in Los Angeles County. Cancer Causes and Control, 25, 1233–1237.
34. Ogmundsdottir, H.M., Haraldsdottirm, V., Johannesson, G.M., Olafsdottir, G., Bjarnadottir, K., Sigvaldason, H. & Tulinius, H. (2005) Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families. Haematologica, 90, 66–71.
35. Orsi, L., Delabre, L., Monnereau, A., Delval, P., Berthou, C., Fenaux, P., Marit, G., Soubeyran, P., Huguet, F., Milpied, N., Leporrier, M., Hemon, D., Troussard, X. & Clavel, J. (2009) Occupational exposure to pesticides and lymphoid neoplasms among men: results of a French case-control study. Occupational and Environmental Medicine, 66, 291–298.
36. Perrotta, C., Staines, A., Codd, M., Kleefeld, S., Crowley, D., T'Mannetje, A., Becker, N., Brennan, P., De Sanjosé, S., Foretova, L., Maynadie, M., Nieters, A., Boffetta, P. & Cocco, P. (2012) Multiple Myeloma and lifetime occupation: results from the EPILYMPH study. Journal of Occupational Medicine and Toxicology, 7, 25.
37. Purdue, M.P., Lan, Q., Menashe, I., Zheng, T., Zhang, Y., Yeager, M., Hosgood, III, H.D., Zahm, S.H., Chanock, S.J., Rothman, N. & Baris, D. (2011) Variation in innate immunity genes and risk of multiple myeloma. Hematology Oncology, 29, 42–46.
38. Rothman, K. & Greenland, S. (1998) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA.
39. Shoenfeld, Y., Berliner, S., Shaklai, M., Gallant, L.A. & Pinkhas, J. (1982) Familial multiple myeloma. A review of thirty-seven families. Postgraduate Medical Journal, 58, 12–16.
40. Steingrimsdottir, H., Einarsdottir, H.K., Haraldsdottir, V. & Ogmundsdottir, H.M. (2011) Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members. European Journal of Haematology, 86, 396–404.
41. Vachon, C.M., Kyle, R.A., Therneau, T.M., Foreman, B.J., Larson, D.R., Colby, C.L., Phelps, T.K., Dispenzieri, A., Kumar, S.K., Katzmann, J.A. & Rajkumar, S.V. (2009) Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood, 114, 785–790.
42. Vangsted, A., Klausen, T.W. & Vogel, U. (2012) Genetic variations in multiple myeloma I: effect on risk of multiple myeloma. European Journal of Haematology, 88, 8–30.
43. VanValkenburg, M.E., Pruitt, G.I., Brill, I.K., Costa, L., Ehtsham, M., Justement, I.T., Innis-Shelton, R.D., Salzman, D., Reddy, E.S., Godby, K.N., Mikhail, F.M., Carroll, A.J., Reddy, V.B., Sanderson, R.D., Justement, L.B., Sanders, P.W. & Brown, E.E. (2016) Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features. Cancer Causes and Control, 27, 81–91.
44. Zahm, S.H., Weisenburger, D.D., Babbitt, P.A., Saal, R.C., Vaught, J.B. & Blair, A. (1992) Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. American Journal of Public Health, 82, 990–997.
45. Ziogas, A. & Anton-Culver, H. (2003) Validation of family history data in cancer family registries. American Journal of Preventative Medicine, 24, 190–198.
46. Ziv, E., Dean, E., Hu, D., Martino, A., Serie, D., Curtin, K., Campa, D., Aftab, B., Bracci, P., Buda, G., Zhao, Y., Caswell-Jin, J., Diasio, R., Dumontet, C., Dudzinski, M., Fejerman, L., Greenberg, A., Huntsman, S., Jamroziak, K., Jurczyszyn, A., Kumar, S., Atanackovic, D., Glenn, M., Cannon-Albright, L.A., Jones, B., Lee, A., Marques, H., Martin, T., Martinez-Lopez, J., Rajkumar, V., Sainz, J., Vangsted, A.J., Watek, M., Wolf, J., Slager, S., Camp, N.J., Canzian, F. & Vachon, C. (2015) Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nature Communications, 6, 7539.
47. Zwick, C., Held, G., Auth, M., Bernal-Mizrachi, L., Roback, J.D., Sunay, S., Iida, S., Kuroda, Y., Sakai, A., Ziepert, M., Ueda, R., Pfreundschuh, M. & Preuss, K.D. (2014) Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM. International Journal of Cancer, 135, 934–938.